Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2023
Source ID
10.1016/j.jtct.2022.12.017

Entities

People

  • Alan Howard
  • Alisha Mussetter
  • Antonio Martin Jimenez-jimenez
  • Asif Alavi
  • Brent R. Logan
  • Brian C. Shaffer
  • Bronwen E Shaw
  • Claudio Anasetti
  • Dennis L Confer
  • Farhad Khimani
  • Hannah Choe
  • Javier BolaƱos-meade
  • John M. Mccarty
  • Joseph A. Pidala
  • Katarzyna Jamieson
  • Krishna V. Komanduri
  • Leo Luznik
  • Linda J. Burns
  • Mary M. Horowitz
  • Maxim Norkin
  • Miguel-Angel Perales
  • Nancy M. Hardy
  • Nirav N. Shah
  • Nosha Farhadfar
  • Richard F. Ambinder
  • Stephen R. Spellman
  • Steven M Devine
  • Voravit Ratanatharathorn
  • Xiao-Ying Tang

Organizations

  • Health Resources and Services Administration
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • Office of Naval Research

Tags

Technology Areas

  • Biotechnology